Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin

Cancer Research

Volumn 58, Issue 24, 1998, Pages 5686-5689

  Gorski, David H ^a   Mauceri, Helena J ^a   Salloum, Rabih M ^a   Gately, Stephen ^b   Hellman, Samuel ^a   Beckett, Michael A ^a   Sukhatme, Vikas P ^c   Soff, Gerald A ^b   Kufe, Donald W ^d   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CANCER THERAPY; CONTROLLED STUDY; FEMALE; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PLASMINOGEN; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 17444376781     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Thomas, K. A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem., 277: 603-606, 1996.
2. Wang, Y., and Decker, D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-I in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat. Med., 3: 887-893, 1997.
3. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
4. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., I: 27-31, 1995.
5. Hanahan, D., Christofori, G., Naik, P., and Arbeit, J. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur. J. Cancer, 32A: 2386-2393, 1996.
6. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
7. Fidler, I. J., and Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
8. 121. Cancer Res., 55: 5296-5301, 1995.
9. Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., Thomas, K. A., and Curiel, D. T. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Nail. Acad. Sci. USA, 95: 8795-8800, 1998.
10. Lin, P., Sankar, S., Shan, S., Dewhirst, M. W., Polverini, P. J., Quinn, T. Q., and Peters, K. G. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Differ., 9: 49-58, 1998.
11. Lin, P., Buxton, J. A., Acheson, A., Radzicjewski, C., Maisonpierre, P. C., Yancopoulos, G. D., Channon, K. M., Hale, L. P., Dewhirst, M. W., George, S. E., and Peters, K. G. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc .Natl. Acad. Sci. USA, 95: 8829-8834, 1998.
12. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen. C, Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
13. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
14. Gately, S., Twardowski, P., Stack, M. S., Patrick, M., Boggio, L., Cundiff, D. L., Schnaper, H. W., Madison, L., Volpert, O., Bouck, N., Enghild, J., Kwaan, H. C., and Soff, G. A. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res., 56: 4887-4890, 1996.
15. Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild. J., Kwaan, H. C., Lee, F., Kramer, R. A., Volpert, O., Bouck, N., and Soff, G. A. The mechanism of cancer-mediated conversion of plasminogen to angiogenesis inhibitor angiostatin. Proc. Natl. Acad. Sci. USA, 94: 10868-10872, 1997.
16. Stathakis, P., Fitzgerald, M., Matthias, L. J., Chesterman, C. N., and Hogg, P. J. Generation of angiostatin by reduction and proteolysis of plasmin: catalysis by a plasmin reductase secreted by cultured cells. J. Biol. Chem., 272: 20641-20645, 1997.
17. Dong, Z., Kumar, R., Yang, X., and Fidler, I. J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell, 88: 801-810, 1997.
18. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Amiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lend) 390404-407, 1997.
19. O'Reilly, M. S., Holmgren, L., Chen, C, and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996.
20. Griscelli, F., Li, H., Bennaceur-Griscelli, A., Soria, J., Opolon, P., Soria, C., Perricaudet, M., Yeh, P., and Lu, H. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest Proc. Natl. Acad. Sci. USA, 95; 6367-6372, 1998.
21. Tanaka, T., Cao, Y., Folkman, J., and Fine, H. A. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res., 58: 3362-3369, 1998.
22. Mauceri, H., Hanna, N., Beckett, M., Gorski, D. H., Staba, M. J., Stellato, K. A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., Soff, G., Sukhatme, V. P., Kufe, D., and Weichselbaum, R. R. Interaction of angiostatin and ionizing radiation in anti-tumour therapy. Nature (Lond.), 394: 287-291, 1998.